PT - JOURNAL ARTICLE AU - Elgarhi, N AU - Kreuz, J AU - Balta, O AU - Nickenig, G AU - Hoium, H AU - Lewalter, T AU - Schwab, J Otto TI - Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator AID - 10.1136/hrt.2006.112730 DP - 2008 Apr 01 TA - Heart PG - e16--e16 VI - 94 IP - 4 4099 - http://heart.bmj.com/content/94/4/e16.short 4100 - http://heart.bmj.com/content/94/4/e16.full SO - Heart2008 Apr 01; 94 AB - Objective: Evaluation of the significance of the Wedensky Modulation (WM) examination for ventricular tachyarrhythmias (VT) in patients with coronary artery disease and implantable cardioverter-defibrillator therapy (ICD).Design: Prospective, single-centre study conducted from 2004 to 2006.Setting: University of Bonn, Department of Medicine – Cardiology, Bonn, Germany.Patients: 37 consecutive patients with coronary artery disease receiving an ICD for primary or secondary prevention.Main outcome measures: Correlation of a positive WM-Index (WMI) with established non-invasive Holter parameter, the occurrence of VT after ICD implantation with regard to primary or secondary prevention, and inducibility of VT during electrophysiological (EP) studies.Results: The WMI was positive in 15 patients (67 (SD 8) years, 31% (SD 12%) EF) and showed significant correlation with heart rate variability (standard deviation of normal to normal intervals (SDNN): 143 (SD 80) ms vs 102 (SD 29) ms, p = 0.04, r = 0.45; total power (TP). 11 885 (SD 19 674) ms2 vs 2229 (SD 1779) ms2, p = 0.03, r = 0.384; very low frequency component (VLF): 2777 (SD 3039) ms2 vs 1184 (SD 565) ms2, p = 0.03; low frequency component (LF): 2955 (SD 5734) ms2 vs 468 (SD 725) ms2, p = 0.05, r = 0.375; high frequency component (HF): 4885 (SD 9939) ms2 vs 382 (SD 609) ms2, p = 0.05, r = 0.315) and turbulence (turbulence onset (TO): −0.002 (SD 0.008) vs +0.005 (SD 0.01), p = 0.05, r = 0.301; turbulence slope (TS): 3.4 (SD 3.1) vs 1.7 (SD 1.5), p = 0.04, r = 0.419). The positive predictive value of the WMI considering the inducibility of VT during EP testing was 100%. Those patients who received an ICD for primary prevention showed a higher WMI (p = 0.049) than the secondary prevention group. With respect to the occurrence of adequate VT episodes, a negative WM test result demonstrated a negative predictive value of 95%.Conclusion: The data presented show that the WM-Index predicts VT inducibility during EP testing and indicates a high negative predictive value regarding the occurrence of VT.